<!DOCTYPE html>
<html>
<head>
<title>Cluster4-12 Analysis</title>

    <style>
            body {{
                font-family: Arial, sans-serif;
                background-color: #f5f5f5;
                color: #333333;
                margin: 0;
                padding: 0;
            }}

            h1 {{
                font-size: 2em;
                margin: 0 0 0.5em;
            }}

            ul {{
                list-style-type: none;
                margin: 0;
                padding: 0;
            }}

            li {{
                font-size: 1.2em;
                margin: 0;
            }}

            .container {{
                max-width: 800px;
                margin: 0 auto;
                padding: 2em;
                background-color: #ffffff;
            }}
        </style> 
        
</head>
<body>
<h1>Cluster4-12 System Summary</h1>
<h2>Proteins</h2>
<p>ALMS1, ARMCX5, BORCS7, CRY2, CSTPP1, GNAQ, GNB5, IFT57, INTS5, LIMK1, LMTK2, MAGEA4, MAPK14, PLEKHN1, PPP1R16B, PRKAA1, SMC4, TAB1, TAB3, TSC22D3</p>
<h2>GPT 4 Analysis</h2><h3> Cytosolic-Nuclear Signal Transduction and Protein Kinase System </h3><h4>Summary</h4><div><summary><br>The human protein system analyzed in this study consists of 20 proteins, with a majority involved in protein binding, cytosolic and nuclear localization, and signal transduction. The system appears to be involved in various cellular processes, including protein phosphorylation, GTPase activity, and response to cellular stress. Based on the functions and locations of the proteins, the system can be named the "Cytosolic-Nuclear Signal Transduction and Protein Kinase System."<br></summary></div><h4>Reference</h4><div><references><br>1. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002 Dec 6;298(5600):1912-34. doi: 10.1126/science.1075762. PMID: 12471243.<br>2. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S</references></div>
<h2>Gene Feature Summary</h2>
<table>
<thead>
<tr>
<th>Feature</th><th>Number of Genes</th><th>Genes</th></tr>
</thead>
<tbody>
<tr>
<td>protein binding</td><td>19</td><td>ARMCX5, BORCS7, CRY2, CSTPP1, GNAQ, GNB5, IFT57, INTS5, LIMK1, LMTK2, MAGEA4, MAPK14, PLEKHN1, PPP1R16B, PRKAA1, SMC4, TAB1, TAB3, TSC22D3</td></tr>
<tr>
<td>cytosol</td><td>12</td><td>ALMS1, CRY2, GNB5, INTS5, LIMK1, LMTK2, MAPK14, PRKAA1, SMC4, TAB1, TAB3, TSC22D3</td></tr>
<tr>
<td>nucleus</td><td>10</td><td>CRY2, GNB5, INTS5, LIMK1, MAGEA4, MAPK14, PPP1R16B, PRKAA1, SMC4, TSC22D3</td></tr>
<tr>
<td>cytoplasm</td><td>9</td><td>CRY2, CSTPP1, GNAQ, GNB5, INTS5, LIMK1, MAPK14, PPP1R16B, PRKAA1</td></tr>
<tr>
<td>nuclear speck</td><td>7</td><td>CRY2, LIMK1, MAPK14, PPP1R16B, PRKAA1, SMC4, TAB1</td></tr>
<tr>
<td>ATP binding</td><td>5</td><td>LIMK1, LMTK2, MAPK14, PRKAA1, SMC4</td></tr>
<tr>
<td>plasma membrane</td><td>4</td><td>GNAQ, PLEKHN1, PPP1R16B, TAB3</td></tr>
<tr>
<td>signal transduction</td><td>4</td><td>GNB5, LIMK1, MAPK14, PRKAA1</td></tr>
<tr>
<td>nucleoplasm</td><td>4</td><td>INTS5, MAPK14, PRKAA1, SMC4</td></tr>
<tr>
<td>protein serine/threonine kinase activity</td><td>4</td><td>LIMK1, LMTK2, MAPK14, PRKAA1</td></tr>
<tr>
<td>protein serine kinase activity</td><td>4</td><td>LIMK1, LMTK2, MAPK14, PRKAA1</td></tr>
<tr>
<td>mitochondrion</td><td>3</td><td>CRY2, MAPK14, PLEKHN1</td></tr>
<tr>
<td>metal ion binding</td><td>3</td><td>GNAQ, LIMK1, PRKAA1</td></tr>
<tr>
<td>Golgi apparatus</td><td>3</td><td>GNAQ, IFT57, LMTK2</td></tr>
<tr>
<td>membrane</td><td>3</td><td>INTS5, LIMK1, LMTK2</td></tr>
<tr>
<td>protein kinase activity</td><td>3</td><td>LIMK1, LMTK2, PRKAA1</td></tr>
<tr>
<td>protein phosphorylation</td><td>3</td><td>LIMK1, LMTK2, PRKAA1</td></tr>
<tr>
<td>molecular_function</td><td>2</td><td>ALMS1, MAGEA4</td></tr>
<tr>
<td> stress fiber assembly</td><td>2</td><td>ALMS1, LIMK1</td></tr>
<tr>
<td>spindle pole</td><td>2</td><td>ALMS1, MAPK14</td></tr>
<tr>
<td>centrosome</td><td>2</td><td>ALMS1, IFT57</td></tr>
<tr>
<td>cilium</td><td>2</td><td>ALMS1, IFT57</td></tr>
<tr>
<td>DNA binding</td><td>2</td><td>CRY2, IFT57</td></tr>
<tr>
<td>single-stranded DNA binding</td><td>2</td><td>CRY2, SMC4</td></tr>
<tr>
<td>negative regulation of transcription by RNA polymerase II</td><td>2</td><td>CRY2, MAGEA4</td></tr>
<tr>
<td>response to activity</td><td>2</td><td>CRY2, PRKAA1</td></tr>
<tr>
<td>response to insulin</td><td>2</td><td>CRY2, MAPK14</td></tr>
<tr>
<td>glucose homeostasis</td><td>2</td><td>CRY2, PRKAA1</td></tr>
<tr>
<td> circadian rhythm</td><td>2</td><td>CRY2, PRKAA1</td></tr>
<tr>
<td>extracellular region</td><td>2</td><td>CRY2, MAPK14</td></tr>
<tr>
<td>enzyme activator activity</td><td>2</td><td>CSTPP1, TAB1</td></tr>
<tr>
<td>GTPase activity</td><td>2</td><td>GNAQ, GNB5</td></tr>
<tr>
<td>GTPase activator activity</td><td>2</td><td>GNAQ, GNB5</td></tr>
<tr>
<td>heterotrimeric G-protein complex</td><td>2</td><td>GNAQ, GNB5</td></tr>
<tr>
<td>nuclear membrane</td><td>2</td><td>GNAQ, INTS5</td></tr>
<tr>
<td>extracellular exosome</td><td>2</td><td>GNAQ, TAB3</td></tr>
<tr>
<td>apoptotic process</td><td>2</td><td>IFT57, MAPK14</td></tr>
<tr>
<td> apoptotic process</td><td>2</td><td>IFT57, PLEKHN1</td></tr>
<tr>
<td>cytoskeleton</td><td>2</td><td>LIMK1, PLEKHN1</td></tr>
<tr>
<td>peptidyl-serine phosphorylation</td><td>2</td><td>LMTK2, MAPK14</td></tr>
<tr>
<td>neuronal cell body</td><td>2</td><td>LMTK2, PRKAA1</td></tr>
<tr>
<td>perinuclear region of cytoplasm</td><td>2</td><td>LMTK2, PPP1R16B</td></tr>
<tr>
<td>negative regulation of apoptotic process</td><td>2</td><td>MAGEA4, PRKAA1</td></tr>
<tr>
<td>mitogen-activated protein kinase p38 binding</td><td>2</td><td>MAPK14, TAB1</td></tr>
<tr>
<td>glucose metabolic process</td><td>2</td><td>MAPK14, PRKAA1</td></tr>
<tr>
<td> transcription by RNA polymerase II</td><td>2</td><td>MAPK14, TSC22D3</td></tr>
<tr>
<td> gene expression</td><td>2</td><td>MAPK14, PRKAA1</td></tr>
<tr>
<td>fatty acid oxidation</td><td>2</td><td>MAPK14, PRKAA1</td></tr>
<tr>
<td>intracellular signal transduction</td><td>2</td><td>MAPK14, PRKAA1</td></tr>
<tr>
<td>response to hypoxia</td><td>2</td><td>PLEKHN1, PRKAA1</td></tr>
<tr>
<td>chromatin binding</td><td>2</td><td>PRKAA1, SMC4</td></tr>
<tr>
<td>protein-containing complex binding</td><td>2</td><td>PRKAA1, TAB1</td></tr>
<tr>
<td>endosome membrane</td><td>2</td><td>TAB1, TAB3</td></tr>
</tbody>
</table>
</body>
</html>